Cita APA (7a ed.)

Kudo, M. (2021). A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion. Karger Publishers.

Cita Chicago Style (17a ed.)

Kudo, Masatoshi. A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion. Karger Publishers, 2021.

Cita MLA (8a ed.)

Kudo, Masatoshi. A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion. Karger Publishers, 2021.